Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe.
Damon WillemsEva-Lotta HinzpeterHessel H Van der ZeeChristopher J SayedJohn R IngramCharlotte BeaudartSilvia M A A EversMickaël J C HiligsmannPublished in: The patient (2023)
This study revealed the most important treatment characteristics for patients with hidradenitis suppurativa that can help inform joint patient-physician decision making in the management of hidradenitis suppurativa. Designing future hidradenitis suppurativa treatments according to stated preferences, namely, to offer higher levels of effectiveness and pain improvement without higher risks of adverse events, may increase patients' treatment concordance and lead to improved disease management outcomes.
Keyphrases
- hidradenitis suppurativa
- end stage renal disease
- case report
- randomized controlled trial
- newly diagnosed
- emergency department
- primary care
- systematic review
- chronic pain
- ejection fraction
- peritoneal dialysis
- pain management
- risk assessment
- adipose tissue
- prognostic factors
- current status
- human health
- insulin resistance
- patient reported